文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

阻塞性睡眠呼吸暂停对创伤性脑损伤结局的影响:回顾性队列分析

Effect of Obstructive Sleep Apnea on Outcomes After Traumatic Brain Injury: A Retrospective Cohort Analysis.
PubMed 文献 · Neurocrit Care · 2022-03-31
一句话结论创伤性脑损伤合并既存阻塞性睡眠呼吸暂停诊断者院内死亡率更低(OR 0.58;p < 0.001),但呼吸系统并发症与急性心力衰竭风险更高。

该研究回顾性分析美国国家住院患者样本(NIS)数据库2005至2015年成人(≥18岁)创伤性脑损伤(TBI)患者,比较有和无既存阻塞性睡眠呼吸暂停(OSA)诊断者的院内结局。TBI队列中OSA患病率为0.90%;OSA组多为肥胖或病态肥胖的老年男性、合并症负担高、头部损伤更重,但接受开颅或去骨瓣减压术的比例更低。倾向性评分匹配后,OSA组院内死亡风险显著更低(OR 0.58;p < 0.001),呼吸系统并发症(OR 1.23)和急性心力衰竭(OR 1.25)风险更高,急性心肌梗死(OR 0.73)、心源性休克(OR 0.34)和输注浓缩红细胞(OR 0.79)风险更低;OSA组平均住院时间较非OSA组少0.3天(7.4 vs. 7.7天)。作者认为既存OSA可能通过缺氧-缺血预处理等保护性生理改变降低神经创伤后死亡率。

要点

  • TBI合并既存OSA诊断者院内死亡风险显著更低(OR 0.58;p < 0.001)。
  • OSA组呼吸系统并发症风险更高(OR 1.23),急性心力衰竭风险更高(OR 1.25)。
  • OSA组急性心肌梗死(OR 0.73)、心源性休克(OR 0.34)及输注浓缩红细胞(OR 0.79)风险更低。
  • OSA组平均住院时间较非OSA组少0.3天(7.4 vs. 7.7天)。
  • OSA组患者多为肥胖或病态肥胖的老年男性、合并症负担高、头部损伤更重,但接受开颅或去骨瓣减压术的比例更低。

适用人群与场景

  • 美国国家住院患者样本(NIS)数据库中2005至2015年住院的成人(年龄≥18岁)患者,主要诊断为创伤性脑损伤(TBI)。
  • 按有无既存阻塞性睡眠呼吸暂停(OSA)诊断分为两组进行比较。

研究设计与关键结果

  • 研究类型:回顾性队列分析;数据来源:美国国家住院患者样本(NIS)数据库;人群:2005至2015年成人(≥18岁)主要诊断为TBI的住院患者;暴露:既存OSA诊断;对照:无既存OSA诊断;主要终点:院内死亡、住院时间、院内并发症;方法:倾向性评分匹配和条件logistic回归模型。
  • TBI队列中诊断OSA的总体患病率为0.90%。
  • OSA组患者多为肥胖或病态肥胖的老年男性、合并症负担高、头部损伤更重,但接受开颅或去骨瓣减压术的比例更低。
  • 倾向性评分匹配后,OSA组院内死亡风险显著更低(OR 0.58;p < 0.001)。
  • 与非OSA组相比,OSA组呼吸系统并发症风险更高(OR 1.23)、急性心力衰竭风险更高(OR 1.25)。
  • 与非OSA组相比,OSA组急性心肌梗死风险更低(OR 0.73)、心源性休克风险更低(OR 0.34)、输注浓缩红细胞风险更低(OR 0.79)。
  • OSA组平均住院时间较非OSA组少0.3天(7.4 vs. 7.7天)。

证据类型、等级与局限

  • 证据类型:回顾性队列分析(基于美国国家住院患者样本数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,既存OSA可能通过缺氧-缺血预处理等保护性生理改变(尤其对心脏和神经组织)在神经创伤后提供保护,从而可能降低死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) and obstructive sleep apnea (OSA) are common in the general population and are associated with significant morbidity and mortality. The objective of this study was to assess hospital outcomes of patients with TBI with and without a pre-existing OSA diagnosis.

METHODS: We retrospectively analyzed data from the National Inpatient Sample (NIS) database of adult patients aged ≥ 18 years with a primary diagnosis of TBI. In-hospital outcomes were assessed among patients with TBI with and without pre-existing OSA hospitalized between 2005 to 2015 in the United States. Propensity score matching and conditional logistic regression models were used to analyze in-hospital mortality, length of hospitalization, and in-hospital complications among patients with TBI with and without a pretrauma OSA diagnosis.

RESULTS: In our TBI cohort, the overall prevalence of diagnosed OSA was 0.90%. Patients with OSA were mostly obese or morbidly obese older men with high comorbidity burden and sustained more severe head injuries yet were less likely to undergo craniotomy or craniectomy. Following propensity score matching, the odds risk (OR) of in-hospital mortality was significantly lower in the OSA group with TBI (OR 0.58; p < 0.001). Compared with the non-OSA group, patients with OSA had significantly higher risk of respiratory complications (OR 1.23) and acute heart failure (OR 1.25) and lower risk of acute myocardial infarction (OR 0.73), cardiogenic shock (OR 0.34), and packed red blood cell transfusions (OR 0.79). Patients with OSA spent on average 0.3 days less (7.4 vs. 7.7 days) hospitalized compared with the non-OSA group.

CONCLUSIONS: Patients with TBI with underlying OSA diagnosis were older and had higher comorbidity burden; however, hospital mortality was lower. Pre-existing OSA may result in protective physiologic changes such as hypoxic-ischemic preconditioning especially to cardiac and neural tissues, which can provide protection following neurological trauma, which may lead to a reduction in mortality.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Mubashir T, Ahmad HS, Lai H, et al. Effect of Obstructive Sleep Apnea on Outcomes After Traumatic Brain Injury: A Retrospective Cohort Analysis. Neurocrit Care. 2022. PMID: 35355216. doi:10.1007/s12028-022-01479-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。